GN, as a disease category, is one of the leading causes of progressive renal failure leading to ESRD. 1 Among the different types of GN, crescentic GN is the most aggressive form with the worst prognosis. Crescentic GN represents a heterogeneous collection of disease entities, such as ANCA-associated GN and antiglomerular basement membrane (anti-GBM) nephritis. 2 Cell-mediated renal damage is, however, a fundamental characteristic of each form of crescentic GN. 3, 4 Nephrotoxic nephritis (NTN) is a well established murine model of crescentic GN. 5 In this model, a sheep antiserum raised against kidney cortical components is injected into mice, resulting in activation of Th1 and Th17 cells in lymphatic organs. Because of their specificity, sheep Igs are preferentially deposited in the kidney, inducing tissue destruction by infiltrating activated Th1 and Th17 cells. [6] [7] [8] These cells subsequently activate intrarenal macrophages and drive neutrophil recruitment, causing renal tissue injury. 9 Dendritic cells (DCs) are professional antigenpresenting cells that play a pivotal role in the priming and activation of effector T cells, but under certain circumstances, they might also protect against an overwhelming inflammatory response by less well characterized mechanisms. Renal DCs form an extensive parenchymal network that spans the entire tubulointerstitium, ensuring complete surveillance of the kidney to protect it, for example, against infections ascending through the tubular system. Despite their absence from glomeruli, renal DCs are also involved in GN by capturing glomerular antigens or antigens filtered in glomeruli and presenting them to T effector cells, thereby triggering an inflammatory mononuclear infiltrate in the tubulointerstitium that drives renal disease. 10, 11 It is important to note that renal DCs only exert this pathogenic effect when nephritis becomes chronic (DC maturation). 12 At steady state and in acute GN, they can also mediate anti-inflammatory and disease-attenuating effects. 13 Generally, immature DCs are thought to induce immune tolerance, and this finding is thought to result from the absence of costimulatory signals. 14, 15 It is unclear whether this tolerance causes the protective function of immature kidney DCs.
Recent studies showed that renal DCs significantly contribute to the early production of chemokines and other inflammatory mediators, which regulates the recruitment of leukocytes into the inflamed kidney. 16 We were, therefore, interested in studying whether renal DCs promote the infiltration of potentially anti-inflammatory leukocyte subsets in the early course of experimental GN (NTN) and characterizing the underlying mechanisms.
RESULTS

DC Depletion Reduced the Recruitment of AntiInflammatory Invariant Natural Killer T Cells in Experimental GN
To evaluate the protective mechanisms of DCs in early stages of NTN, CD11c + DCs were depleted on day 3 after induction of nephritis by injecting CD11c.LuciDTR 17 mice with diphtheria toxin (DTx). After 24 hours, renal leukocyte composition was analyzed. As expected, the number of renal DCs was reduced in the DTx group under both control and nephritic conditions (1. Figure 1A , center panel), whereas the proportion of other immune cells, such as CD3 + T cells ( Figure 1A , right panel) and CD11b + macrophages (data not shown), remained unchanged. DTx-induced DC depletion had no effect on systemic numbers of iNKT cells in CD11cLuciDTR mice (Supplemental Figure 1) .
A role for NKT and iNKT cells in the suppressive activity of immature DCs is supported by previous studies showing that these cells can ameliorate experimental GN. 18, 19 In agreement with these results, real-time PCR analysis of FACS-sorted iNKT cells from the kidneys of nephritic wild-type mice showed increased expression of the anti-inflammatory mediators IL-4, IL-10, and TGFb but not the proinflammatory mediator IFNg compared with untreated control mice. Expression of IL-17 was not detectable (data not shown; IL-4: 4.6-fold versus controls; IL-10: 5.9-fold versus controls; TGFb: 15.2-fold versus controls; IFNg: 1.8-fold versus controls) ( Figure 1B ).
CXCR6 Is Highly Expressed on Renal iNKT Cells
The regulation of renal iNKT cell infiltration is largely unknown. Several chemokine receptors, including CXCR3, CCR5, CCR6, and CXCR6, have been reported to promote NKT and iNKT cell trafficking under inflammatory conditions. 20 We, therefore, analyzed the expression profile of these chemokine receptors in renal iNKT cells. More than 90% of renal iNKT cells during the early stages of NTN were CXCR6-positive, whereas CXCR3 (9%), CCR6 (19%) , and CCR5 (11%) expression was much less frequent (Figure 2, A and B) . By contrast, only about 40% of renal CD4 + T cells and CD8 + T cells were CXCR6 + , and less than 10% of CD11b + macrophages and , and T cells (CD45 + CD3 + ) at day 4 of NTN 1 day after DTx injection (numbers represent total cells/kidney; n=3-4/group). (B) Real-time RT-PCR analysis of FACS-sorted iNKT cells for IL-4, IL-10, TGFb, and IFNg isolated from kidneys of nephritic wild-type mice and wild-type controls (n=3-13/group). Bars represent means 6 SD (*P,0.05, **P,0.01, ***P,0.001).
CD19
+ B cells showed CXCR6 expression (data not shown). The specificity of CXCR6 staining was confirmed by simultaneous analysis of renal leukocytes from nephritic CXCR6-deficient mice. These findings suggest a role for CXCR6 in iNKT cell recruitment to the kidney in early NTN.
Renal DCs Produce CXCL16 in the Early Stage of NTN If CXCR6 is linked to the protective effect of iNKT cells in early NTN, its unique ligand CXCL16 should be expressed in the kidney. To test this hypothesis, we performed real-time PCR to quantify renal CXCL16 expression in nephritic mice at four different time points. mRNA expression of CXCL16 in the kidneys of nephritic wild-type mice peaked 5 days after induction of nephritis and remained elevated until the last time point analyzed (that is, at day 20 after induction of the disease) ( Figure 2C ). mRNA expression of CXCR6 in the kidneys of nephritic wild-type mice was also increased from day 5 on after induction of nephritis ( Figure 2D ).
To localize renal CXCL16 expression, we performed in situ hybridization experiments ( Figure 2E ) and found that mRNA expression of CXCL16 in nephritic mice was predominantly present in periglomerular and tubulointerstitial infiltrates, whereas intraglomerular CXCL16 signals were apparently restricted to cellular crescents and single infiltrating cells in the glomerular tuft. The periglomerular expression pattern of CXCL16 ( Figure 2E ) was strikingly reminiscent of the location of renal DCs in NTN, which was revealed by immunohistochemical staining for the DC marker CD11c in nephritic mice ( Figure 2F ). To test whether renal DCs might contribute to renal CXCL16 production, we analyzed the mRNA levels of this chemokine by quantitative RT-PCR in magnetic activated cell sorting (MACS)-sorted DCs isolated from kidneys at different time points after induction of nephritis. CXCL16 expression by renal DCs peaked at day 4 after induction of nephritis (4.8-fold higher than control) and subsequently declined at day 8 (2.8-fold higher than control) ( Figure 2G ). This finding suggests that the suppressive modes of action of immature renal DCs and iNKT cells are associated with the CXCL16-CXCR6 axis. These findings do not exclude a contribution of other cells to renal CXCL16 production.
Critical Role of the CXCL16-CXCR6 Axis in Renal iNKT Cell Localization and Function
To determine whether the CXCL16-CXCR6 axis is functionally relevant to NTN, we first analyzed whether CXCR6 deficiency affects the recruitment of iNKT cells to the inflamed kidney. We were able to detect iNKT cells in the kidneys of nephritic wild-type and CXCR6-deficient mice and found that the frequency ( Figure 3A ) and numbers (not shown) of iNKT cells were reduced in the kidneys of nephritic CXCR6-deficient mice. Quantification of their frequency showed one-half as many Tetramer + TCRb + iNKT cells in CXCR6-deficient mice compared with wild-type mice (percent of CD3 cells; WT: 2.560.7%; CXCR6 2/2 : 1.260.6%; P,0.01) ( Figure 3B ). In addition to renal iNKT cell localization, the CXCL16-CXCR6 axis might also promote the production of anti-and proinflammatory cytokines, such as IL-4, IL-10, and IFNg, by iNKT cells. This assumption was investigated by intracellular IL-4 and IFNg staining of renal iNKT cells of nephritic wild-type and CXCR6-deficient mice. IL-4 expression was significantly reduced in iNKT cells from CXCR6-deficient mice (WT: 24.964.9%; CXCR6 : 52.366.0%) (Figure 3, E and F) . Next, we analyzed whether DC-NKT cell interaction/activation was CXCR6-dependent. We, therefore, purified hepatic NKT cells from wild-type and CXCR6-deficient mice by FACS sorting (purity.95%) followed by stimulation with a-GalCer using mouse myeloid DCs as antigen-presenting cells. The production of IL-4, IL-10, and IFNg was strongly induced by a-GalCer in DC cocultures with wild-type NKT cells, whereas CXCR6-deficient NKT cells had a significantly reduced capacity to produce and Figure 4A ). Glomerular changes included hypercellularity and formation of cellular crescents, capillary aneurysms, and intraglomerular deposition of PAS-positive material. Serial fibrin staining showed the presence of fresh glomerular capillary necrosis ( Figure  4A ). The tubulointerstitial compartment showed tubular dilatation, necrosis, and atrophy along with protein casts and tubular protein reuptake caused by proteinuria. To quantify renal tissue damage, PAS-stained kidney sections were evaluated for the presence of crescents, glomerular sclerosis (deposition of PAS-positive material), and tubulointerstitial injury ( Figure 4 , B-D) as previously described. 21 The frequency of glomerular crescents at day 8 was significantly increased in nephritic CXCR6-deficient mice compared with the wild-type group (WT: 33.669.2%; CXCR6 2/2 : 45.668.5%, P,0.001) ( Figure  4B ). Nephritic kidneys showed a higher frequency of glomerulosclerosis (WT: 50.3621.9; CXCR6 2/2 : 66.3614.9, P,0.01) ( Figure 4C ) and considerable tubulointerstitial injury, which was reflected in a significant increase in the interstitial area (WT: 17.564.1%; CXCR6 2/2 : 21.864.8%, P,0.001) ( Figure  4D ).
BUN and serum creatinine levels of nephritic CXCR6-deficient mice were significantly elevated at day 8 (0.4160.12 and 173.7658 .4 mg/dl, respectively) compared with the nephritic wild-type group (0.3260.08 and 132.0664.2 mg/dl, P,0.01 and P,0.05, respectively) ( Figure 4 , E and F).
Nephritic wild-type and CXCR6-deficient mice showed a markedly increased albumin-to-creatinine ratio at day 8 after induction of nephritis compared with controls (P,0.001 versus controls). However, there was no statistically significant difference in albumin excretion between nephritic CXCR6-deficient and nephritic wild-type mice ( Figure 4G ). Figure 5C and Supplemental Figure 2, A and B) . In addition, infiltrating renal macrophages and DCs in nephritic wild-type and CXCR6-deficient mice were analyzed in more detail by FACS, but no major phenotypical differences in terms of MHCII expression, a marker for antigen presentation, and Ly6C, an activation marker, between these two groups could be observed (Supplemental Figure 2 , C and D). The mRNA level of the macrophage and T cell-attracting chemokine CCL2 was significantly upregulated in nephritic CXCR6-deficient mice, whereas no significant differences in renal CCL5, iNOS, IL-12p40, and IL-1b expression could be found (Supplemental Figure  2E) .
Renal T Cell and
To characterize the T cell subtypes in the kidneys of nephritic animals, we performed intracellular flow cytometric analysis for IFNg + /Th1 and IL-17A + /Th17 cells (Figure 5D ). In both nephritic groups, we detected IFNg + and IL-17A + production by renal CD4 + T helper cells but no significant difference between CXCR6-deficient and wild-type mice ( Figures 5, D-F) .
The renal mRNA levels of the proinflammatory mediators TNF-a and (to a lesser degree) CXCL10 were upregulated in nephritic CXCR6-deficient mice, whereas the anti-inflammatory mediators IL-4, IL-10, and TGFb were slightly decreased compared with the nephritic wild-type group ( Figure 5G ).
Next, we were interested to study whether CXCR6 deficiency might result in a defect of renal Treg cell trafficking and thus, an aggravated course of nephritis. FACS analysis revealed that up to 20% of renal Tregs were CXCR6-positive ( Figure 6A ). However, quantification of tubulointerstitial infiltration of FoxP3 + cells revealed no differences between the wild-type and knockout groups, arguing against a unique role for CXCR6 in renal Treg cell trafficking ( Figure 6 , B and C). In line with the protein data, we found similar expression of renal FoxP3 mRNA in both groups ( Figure 6D ).
Humoral and Cellular Nephritogenic Immune Responses
Semiquantitative scoring of glomerular sheep and mouse IgG deposition revealed no differences between nephritic wild-type and knockout mice (Figure 7, A and B) . In line with this finding, wild-type and CXCR6 2/2 mice had similar serum titers of antisheep IgG, IgG1, and IgG2a antibodies directed against the nephritogenic antigen, which was assessed by ELISA ( Figure 7C ).
To address the question of whether CXCR6-deficient mice have an altered systemic cellular immune response, we analyzed splenocytes from nephritic wild-type and CXCR6-deficient mice for the production of IFNg and IL-17 after restimulation with the nephritogenic antigen. ELISA analyses of the cytokine production from cultured splenocytes showed no significant differences in the Th1-associated IFNg and Th17-associated IL-17 levels between the two groups ( Figure 7D ). Furthermore, the frequencies and numbers of CD4 + T cells, CD8 + T cells, CD11b + macrophages, and most importantly, iNKT cells in the spleens ( Figure 7E ) and renal lymph nodes ( Figure 7F ) of nephritic wild-type and CXCR6-deficient mice were almost identical. Taken together, these data strongly argue against an accelerated humoral or cellular systemic nephritogenic immune response or a lymphocyte survival function of the CXCR6-CXCL16 axis as a cause of aggravated nephritis in CXCR6-deficient mice.
Reconstitution of NKT Cells Attenuates Nephritis in CXCR6-Deficient Mice
The aggravation of GN in CXCR6-deficient mice might be caused by the impaired trafficking and function of potentially protective iNKT cells. To prove this hypothesis, we transferred , nephritic wild-type mice (n=23), and nephritic CXCR6-deficient mice (n=20) 8 days after induction of nephritis. (E) BUN levels, (F) serum creatinine, and (G) albumin-to-creatinine ratio of controls (n=13), nephritic wild-type mice (n=23), and nephritic CXCR6-deficient mice (n=20) 8 days after induction of nephritis. Symbols represent individual data points with median values as horizontal lines (*P,0.05, **P,0.01, ***P,0.001).
wild-type NKT cells, isolated by FACS sorting from the livers of naive wild-type mice, to wild-type and CXCR6-deficient mice 12 hours before induction of NTN. We isolated hepatic NKT cells for these transfer experiments, because the liver contains the highest rate of NKT cells in the body. To avoid extensive activation of the isolated cells through the tetramerbound a-GalCer analog PBS57, we used TCRb and NK1.1 as NKT-defining markers for FACS sorting experiments. FACS analysis of isolated NKT cells before transfer revealed that 95% of the isolated cells were TCRb + NK1.1 + , and over 75% coexpressed an invariant glycolipid antigen-recognizing T cell receptor (Supplemental Figure 3 , A and B). In addition, over 80% of the isolated cells were CXCR6-expressing NKT cells (Supplemental Figure 3C ). This result was further confirmed by analysis of enhanced green fluorescent protein (eGFP) expression on hepatic NKT cells isolated from CXCR6 + /eGFP + heterozygous mice (Supplemental Figure  3D) .
Transfer of 1310 6 naive wild-type NKT cells to wild-type and CXCR6-deficient mice 12 hours before induction of nephritis resulted in almost identical histologic tissue injury in both groups at day 8 of nephritis (Figure 8, A and B) . In contrast, without NKT cell transfer, CXCR6 2/2 nephritic mice developed more severe nephritis than wild-type animals ( Figure 8 , A-C). Most important, renal tissue injury in terms of glomerular crescent formation, glomerular sclerosis, and tubulointerstitial damage and functional parameter (serum creatinine level) was significantly reduced in nephritic CXCR6 2/2 after the cell transfer compared with CXCR6-deficient animals that received vehicle treatment (Figure 8 , A-C), thus showing the protective effect of CXCR6-bearing NKT cells in crescentic GN.
Tubulointerstitial CD3 T cell infiltration, infiltration of glomerular T cells, and infiltration of tubulointerstitial F4/80 + macrophages/DCs did not significantly differ between nephritic wild-type and nephritic CXCR6-deficient mice receiving vehicle treatment or NKT cells ( Figure 8D ).
DISCUSSION
In experimental crescentic GN, immature kidney DCs are protective 13 until they mature, when inflammation becomes chronic. 12 The underlying mechanisms remain to be elucidated. We speculated that, in this early phase, DCs might suppress harmful immune responses by recruiting anti-inflammatory leukocytes, and we addressed this hypothesis in NTN, a model of crescentic GN. When we depleted DCs in CD11c.LuciDTRmice with NTN, we noted that iNKT cells but not proinflammatory leukocytes were markedly reduced within the kidney. This finding sparked our interest, because two recent studies had shown a protective role for NKT cells in renal inflammation. Anti-GBM GN was aggravated in NKT cell-deficient CD1d knockout mice, and adoptively transferred NKT cells localized to the inflamed kidney and prevented this phenotype, which was astonishing, because NKT cells cannot recognize antigen in CD1d-deficient mice. 18 Nevertheless, Mesnard et al. 19 performed this experiment 1 year later in Ja18 knockout mice, which are also deficient in NKT cells but possess CD1d that allows transferred NKT cells to recognize antigen. 22 Also, these animals developed more severe nephritis than wild-type mice, verifying the protective role of iNKT cells. 19 These findings led us to hypothesize that the protective capacity of immature renal DCs might be mediated through the recruitment of iNKT cells into the kidney.
The in vivo mechanisms of iNKT cell trafficking to the kidney are unknown. iNKT cells are known to express high amounts of CXCR6, [23] [24] [25] [26] and indeed, over 90% of iNKT cells in the inflamed kidney expressed the chemokine receptor CXCR6. We detected message for its unique ligand CXCL16 in immature DCs isolated from the kidney early after induction of nephritis. This finding identified a new cellular source for this chemokine in addition to human tubular cells and podocytes, which had been previously shown to produce the unique CXCR6 ligand, CXCL16. 27, 28 Moreover, we noted periglomerular CXCL16 expression resembling the periglomerular pattern of renal DCs in both human and experimental Figure 4) , whereas the work by Germanov et al. 26 reported that CXCL16 neutralization reduced the accumulation of NK1.1 + but not NK.1.1 2 iNKT cells in the liver. Most importantly, nephritic CXCR6-deficient mice developed more severe disease. Causality between the reduced iNKT cell recruitment and the aggravated disease in nephritic CXCR6 2/2 mice was supported by the ability of adoptively transferred CXCR6-competent NKT cells to attenuate disease. Developmental defects in the kidney architecture of CXCR6-deficient mice (Supplemental Figure 5 ) and an overwhelming humoral or cellular nephritogenic immune response as alternative explanations were ruled out. Thus, our findings reveal a new mechanism by which immature DCs attenuate immune-mediated disease by harnessing iNKT cells with a regulatory functionality.
In experimental GN, two groups independently reported that (i)NKT cell deficiency exacerbates disease. 18, 19 This finding indicates that (i)NKT cells play a role in suppressing renal autoimmunity, which is in line with our findings. The mechanisms by which regulatory CXCR6 + iNKT cells protect against autoimmune diseases, such as GN, remain to be fully elucidated but likely involve the production of immunomodulatory cytokines, such as IL-4, IL-10, and TGFb. All of these cytokines have been shown to suppress the model of NTN. 13, 30, 31 The work by Mesnard et al. 19 reported that mRNA expression of TGFb was higher in nephritic wild-type compared with iNKT cell-deficient mouse kidneys and that this reduction contributes to disease exacerbation. In line with these findings, we found increased mRNA expression of IL-4, IL-10, and TGFb (but not IFNg) in sorted iNKT cells from nephritic mice. In nephritic CXCR6
2/2 mice, the number of renal iNKT cells was reduced, and the capacity of CXCR6 2/2 iNKT cells to produce IL-4 and IL-10 was disturbed. In accordance, the renal expression of IL-4, IL-10, and TGFb was reduced in nephritic knockout mice, whereas important proinflammatory mediators, such as TNF-a and the chemokines CCL2 and CXCL10, are upregulated and thus, might directly contribute to exacerbation of renal tissue injury in CXCR6 2/2 mice. However, the exact suppressive mechanism of CXCR6 + iNKT cells may be pinpointed in future studies by, for example, adoptively transferring iNKT cells from cytokine-deficient donor mice or generating iNKT cell-specific CXCR6 knockout mice, which are not yet available. So far, we cannot rule out that CXCR6 deficiency on immune cells other than iNKT cells might contribute to the observed effects in nephritic CXCR6 2/2 mice. Moreover, it would be interesting to study whether the adoptively transferred NKT cells migrate to the nephritic kidney, which was previously shown in the work by Yang et al., 18 and locally suppress immune-mediated renal inflammation or if the trafficking of NKT cells to secondary lymphatic organs might also be important for their anti-inflammatory properties.
The CXCR6-CXCL16 axis has previously been shown to recruit proinflammatory CD4 + and CD8 + T cells to the inflamed allografts, vessels, and human joints, resulting in tissue damage. [32] [33] [34] In anti-GBM nephritis, blocking CXCL16 with the use of a polyclonal antiserum attenuated the disease, mainly by hindering macrophage influx. 35 Furthermore, fibroblasts can express CXCR6, and CXCL16 knockout mice showed reduced fibroblast accumulation in unilateral ureteral obstruction, leading to their protection from renal fibrosis. 36 However, recent studies showed that this axis may also exert anti-inflammatory functions. For example, in a murine heart transplant model, the CXCL16-CXCR6 axis plays a pivotal role for the maintenance of transplant tolerance mediated by infiltrating NKT cells. 25 Our present study supports this notion by showing aggravation of crescentic GN in CXCR6 knockout mice. It is possible that the CXCL16-CXCR6 axis attracts iNKT cells to maintain immune homeostasis in acute inflammatory conditions but drives proinflammatory effector T cell infiltration in chronic inflammatory reactions. This proinflammatory NKT cell function might synergize with the function of matured DCs in chronic inflammation at aggravating GN. 12 Regulatory T cells are widely recognized as being protective in various immune-mediated diseases. 37 In NTN, these cells, under the control of CCR6 and CCR7, 38, 39 were also found to attenuate disease. [40] [41] [42] Our present study highlights iNKT cells as a second regulatory lymphocyte subset that can protect against renal tissue injury in experimental GN and also shows that it is under control of a different chemokine system, the CXCR6-CXCL16 axis. However, the extrapolation of findings from murine crescentic GN to the immunopathogenesis of human rapidly progressive glomerulonephritis is restricted, because human iNKT cells present phenotypic differences relative to their murine counterpart. A better understanding of human iNKT cell biology in autoimmune disease, such as the different forms of crescentic GN, is needed before the manipulation of iNKT cells might represent a new therapeutic target in humans.
CONCISE METHODS
Animals
CXCR6-deficient mice (C57BL/6 background) 43 were purchased from The Jackson Laboratory (Bar Harbor, ME), and the CXCR6 2/2 genotype was confirmed by PCR analysis in each animal before experimental use. DC depletion in CD11c.LuciDTR mice has been described recently. 17 Knockout mice underwent embryo transfer to meet the general standards of our institution. Age-matched C57BL/6 wild-type controls also derived from the strain were bred in our animal facility, and all animals were raised in specific pathogen-free conditions. All animal experiments were performed according to national and institutional animal care and ethical guidelines and were approved by the local committees. 0.5 ml NTN serum/mouse as previously described. 40 Controls were injected intraperitoneally with an equal amount of nonspecific sheep IgG. For urine sample collection, mice were housed in metabolic cages for 6 hours. Urinary albumin excretion was determined by standard ELISA analysis (Mice Albumin Kit, Bethyl), whereas urinary creatinine, BUN, and serum creatinine were measured using standard laboratory methods.
Real-Time RT-PCR Analysis
Total RNA of the renal cortex was prepared from murine kidneys according to standard laboratory methods. RNA from FACS-sorted iNKT cells was extracted using an RNeasy mini kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. RT-PCR was performed for 40 cycles (primer sequences are available on request) in a
Step One Plus RT-PCR System (Applied Biosystems, Foster City, CA) as previously described. 44 All samples were run in duplicate and normalized to 18S rRNA.
In Situ Hybridization
In situ hybridization procedures were performed as previously described. 44 In brief, the CXCL16 cRNA probe was labeled by in vitro transcription (Maxiscript Ambion) with a[ 35 S]-UTP (1250 Ci/ mmol; PerkinElmer) of subcloned cDNA corresponding to nucleotides 503-820 of cDNA sequence NM_023158. In situ hybridization was performed on 16-mm cryosections using 1310 6 cpm/slide of the 35 S-labeled antisense or sense RNA probes. After washing, sections were dipped into Kodak NTB nuclear track emulsion and stained with Mayer's Haemalaun.
Morphologic Examinations
Crescent formation and glomerular sclerosis (deposition of PASpositive material) were assessed in 50 glomeruli per mouse in a blinded fashion in PAS-stained paraffin sections. As a measure of tubulointerstitial injury, the interstitial area was estimated by point counting four independent areas of renal cortex per mouse in low magnification fields (2003) as previously described. 21 Paraffin-embedded sections (2 mm) were stained with an antibody directed against CD3 (A0452; Dako, Germany), FoxP3 (FJK-16s; eBiosciences, San Diego, CA), F4/ 80 (BM8; BMA, Germany), MAC-2 (M3/38; Cedarlane, Canada), CD11c (M17/4; BD Pharmingen, Germany), and sheep IgG or mouse IgG (Jackson Immunoresearch Laboratories). Tissue sections were developed using the Vectastain ABC-AP kit (Vector Laboratories, Burlingame, CA). For FoxP3 staining, tissue sections were incubated with a polyclonal rabbit anti-rat secondary antibody (Dako, Germany) and developed using the ZytoChem Plus (AP) Polymer Kit (Zytomed). MAC-2 + and CD3 + cells in 30 glomerular cross-sections and F4/80 + and CD3 + cells in 30 tubulointerstitial hpf (magnification=4003) per kidney were counted by light microscopy in a blinded fashion. For the quantification of FoxP3 + cells, at least 10 low power fields (magnification=2003) were counted. 40 Glomerular mouse IgG deposition was scored from zero to three in 30 glomeruli per mouse as previously described. 38 
Assessment of the Humoral and Cellular Nephritogenic Immune Responses
Mouse anti-sheep IgG antibody titers were measured by ELISA using sera collected 8 days after induction of nephritis as previously described. 40 To analyze the cellular immune response, splenocytes (4310 6 cells/ml) were cultured in RPMI/10% FCS with sheep IgG (10 mg/ml) at 37°C for 72 hours. IFNg and IL-17A concentrations were measured in the supernatants by ELISA as previously described. 40 
Renal Leukocyte Isolation
Previously described methods for leukocyte isolation from murine kidneys were used. 45 In brief, kidneys were finely minced and digested for 45 minutes at 37°C with 0.4 mg/ml collagenase D (Roche, Mannheim, Germany) and 0.01 mg/ml DNAse I in RPMI 1640 (Roche) supplemented with 10% heat-inactivated FCS (Invitrogen). Cell suspensions were sequentially filtered through 70-and 40-mm nylon meshes and washed with HBSS without Ca 2+ and Mg 2+ (Invitrogen). Single-cell suspensions were separated using Percoll density gradient (70% and 40%) centrifugation. The leukocyte-enriched cell suspension was aspirated from the Percoll interface. Cell viability was assessed by trypan blue staining before flow cytometry.
Isolation of Hepatic Leukocytes and Splenocytes and Renal DC Isolation
To isolate hepatic leukocytes, livers were passed through 100-mm nylon meshes, and hepatocytes were removed by centrifugation (8003g for 20 minutes) in 37% Percoll solution (AmershamBiosciences, Freiburg, Germany) containing 100 U/ml heparin at room temperature. For the isolation of splenocytes, spleens were minced and sequentially passed through 70-and 40-mm nylon meshes on ice. After removing the erythrocytes from both cell suspensions using lysis solution (139 mM NH 4 Cl, 19 mM Tris), cells were washed with HBSS and resuspended in FCS-containing buffer. For the isolation of DCs, tissue was digested, and renal single-cell suspensions were resuspended in MACS buffer (500 ml PBS, 0.1% BSA, 2 mM EDTA) and coincubated with mouse-CD11c MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany). After incubation, DCs were positively separated using MACS LS Separation Columns (Miltenyi Biotec, Bergisch Gladbach, Germany). Renal DCs were resuspended in PBS for additional analysis.
Flow Cytometry
For FACS analysis, renal leukocyte suspensions were stained at 4°C for 20 minutes using the following fluorochrome-conjugated antibodies: CD45 (30-F11), CD3 (17A2), CD4 (GK1.5), CD8 (53-6.7), CD25 (PC61.5), CD11b (M1/70), CD19 (1D3), TCRb (H57-597), CD11c(HL3), and NK1.1 (PK136; BD Biosciences, Franklin Lakes, NJ or eBioscience, San Diego, CA). Staining of renal leukocytes using commercially available CXCR6 antibodies resulted in unacceptably high background signals in CXCR6-deficient mice (data not shown); CXCR6 receptor expression was, therefore, detected by using a well characterized CXCL16-Fc fusion protein 23 
NKT Cell Transfer Experiments
Liver CD45 + TCRb + NK1.1 + CD19 2 NKT cells were isolated using a FACS Aria sorter as previously described. 46 Wild-type and CXCR6-deficient mice were intravenously injected with 1310 6 isolated cells in 250 ml PBS per animal followed by induction of nephritis after 12 hours.
In Vitro NKT Cell Stimulation Assays 
Statistical Analyses
The results are shown as the mean 6 SD when presented as a bar graph and the mean with the median when presented as single data points in a scatter dot plot. The results reported in the text are the mean 6 SD. Differences between two individual experimental groups were compared using a two-tailed t test. For multiple comparisons, the one-way ANOVA with Bonferroni multiple comparisons test was used. Experiments that did not yield enough independent data for statistical analysis because of the experimental setup were repeated at least three times. This study was supported by Deutsche Forschungsgemeinschaft Grants KFO 0228 PA 754/7-1 (to J.-E.T. and U.P.) and KU 1063/7-1 (to C.K.).
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Zusammenfassende Darstellung der Publikation
Glomerulonephritiden sind entzündliche Nierenerkrankungen, die nach der diabetischen Nephropathie und der hypertensiven/ischämischen Nephropathie die häufigste Ursache Geweben (Bretscher und Cohn 1970; Steinman, Hawiger et al. 2003) . Doch es gibt auch ortsständige dendritische Zellen in nicht-lymphatischen Geweben wie der Niere. Dort sind sie vor allem im Tubulointerstitium zu finden, wo sie im Entzündungszustand akkumulieren und dort die T-Zellaktivierung, z.B. über IL-10, modifizieren können . Depletionsexperimente zeigen, dass, abhängig vom Zeitpunkt der Depletion der dendritischen Zellen, protektive und aggravierende Effekte im NTN Modell erzielt werden können Hochheiser, Engel et al. 2011 
